Those with PTSD are almost twice as likely to develop alcohol use disorder than their peers who have not experienced trauma. Researchers report drugs that block FKBP5, such as benztropine, a drug used to control symptoms of Parkinson's disease, and the experimental compound SAFit2 reduce alcohol preference and drinking in models of PTSD.
Researchers have identified a set of compounds which could be used to treat MS. These compounds boost a population of progenitor cells which can repair damage to nerve fibers caused by the disease.